Chargement en cours...
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Current drug development in oncology is non-selective as it typically focuses on pathways essential for the survival of all dividing cells. The unique metabolic profile of cancer, which is characterized by increased glycolysis and suppressed mitochondrial glucose oxidation (GO) provides cancer cells...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3590642/ https://ncbi.nlm.nih.gov/pubmed/23471124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00038 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|